October 23, 2026
Hexagon Bio
Biotech company developing novel antibody-drug conjugates and cancer therapeutics.
- Round
- Series C
- Amount raised
- $62M
- Lead investor
- —
- Industry
- Biotechnology
- Headquarters
- Menlo Park
- Employees
- 51-200 employees
- Website
- hexagonbio.com
- View profile →